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We have previously described  (1)  the in vitro isolation of chemically transformed 
cell lines resistant (C type) and sensitive (I type) to rejection mechanisms operative in 
normal mice. The experiments reported here utilize these two classes of transformed 
fibroblastic cell lines (I and C  type) along with the parental nontransformed cell line 
(N type)  to analyze the  resistance or sensitivity of these cell types to natural  killer 
(NK)l-mediated lysis and the specificity of NK cell recognition. 
NK is a term used to describe the lytic activity of spleen cells from naive mice. The 
ability  of NK  cells  to  recognize  and  to  lyse  neoplastic  but  not  normal  cells  has 
suggested  the  hypothesis  that  they  are  involved  in  tumor  surveillance  (2-4).  This 
preferential lysis by NK cells has been interpreted to mean that NK-sensitive target 
cells express surface determinants  recognized by NK cells,  whereas  normal or neo- 
plastic resistant  target  cells do not  express these determinants.  The experiments of 
Roder et al. (5), using lymphoid cell lines, support this hypothesis. They isolated "NK 
target  structures"  and  have shown  that  these  molecules are found on  NK-sensitive 
cells  and  are  absent  on  NK-resistant  cells whether  normal or neoplastic.  Here, we 
show that this conclusion is not valid for all NK targets. 
Fibroblasts  whether  normal  or neoplastic,  which  are  not  lysed  by NK cells,  are 
nevertheless  recognized  by,  but  resistant  to  the  NK effector mechanism.  If NK is 
involved in surveillance of transformed cells, then the presence of NK target structures 
on  NK-resistant  cells  must  limit  the  effectiveness of surveillance  for all  cell  types 
including lymphoid. This finding has as its consequences the following:  (a) for some 
cell types the difference between resistance and sensitivity is not caused by recognition 
but rather by a subsequent step on the pathway to lysis; (b) there are either two types 
of NK lyric signals,  one for lymphoid cells and  another  for fibroblasts, or the  two 
classes of target cells react differently to the same lytic signal; and (c)  if NK activity 
plays a  significant  role in  tumor surveillance, a  special mechanism must operate to 
enable the NK effector to find efficiently and lyse the transformed target. 
Materials and Methods 
Mice.  BALB/c  mice were  from  the  Salk  Institute colony.  Immune-deprived mice were 
prepared by thymectomy of 4- to 6-wk-old mice followed 2 wk later by lethal irradiation (750 
rads)  and reconstituted with  1-2 ×  107 syngeneic  fetal liver cells (ATxFL). 
Cell Lines.  The cell lines are classified as N-, I-, or C-type cells according to the following 
characteristics: 
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Abbreviations used in this paper: ATxFL, an adult thymectomized, lethally irradiated, fetal liver reconsti- 
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Cell type 
In vivo tumorigenic  In vitro 
potential in 
Continous  Growth in  ATxFL  Normal 
cell line  agarose 
Primary fibroblast  .... 
N  type  +  -  -  - 
I type  +  +  +  - 
C  type  +  +  +  + 
The cells studied here were derived as lineages (see top of Figs.  1 and 2), and were maintained 
in Dulbecco's modified Eagle's media plus  10% fetal bovine serum  (FBS).  B/C-N is a  cloned 
fibroblastic cell line derived by us from BALB/c fetal tissue.  It is classified as an N-type cell 
line. The fibroblast population from which it was derived is referred to as primary fibroblasts. 
10ME  HD  A.5  R.1  (10ME)  is  a  cloned  transformed  cell  line derived  from  B/C-N  after 
treatment  with  3-methylcholanthrene-ll,12-dihydroepoxide  (supplied  by  National  Cancer 
Institute Carcinogenesis Research Program). This transformed variant was selected by growth 
in 0.3% agarose then ring cloned, and is classified as an I-type cell line. 
10CR A.2 R. 1 (10CR) is a cloned cell line derived from B/C-N after growth in the presence 
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Fro.  1.  Titration of normal spleen cell NK activity directed against N-, I-, and C-type target cells. 
The targets are B/C-N (A), 10ME (B), L51 (C), and LSB (D). These targets were derived sequentially 
as indicated at the top of the figure, and the classification (N, I, or C) is indicated in the parenthesis 
under each cell line. For more details, see Materials and Methods. 
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F[o.  2.  Titration of normal spleen cell NK activity directed against N-, I-, and C-type target cells. 
The targets are B/C-N (A), 10CR (B), L53 (C), and LSI (D). These targets were derived sequentially 
as indicated at the top of the figure, and the classification (N, I, or C) is indicated in the parenthesis 
under each cell line. For more details, see Materials and Methods. J.  L. COLLINS, P.  Q.  PATEK, AND M.  COHN  91 
of methylcholanthrene crystals. This  transformed  variant  was  selected  by  growth  in  0.3% 
agarose then ring cloned, and is classified as an I-type cell line. 
L50 and L51 are uncloned cell populations established from the tumors that arose in ATxFL 
mice after the subcutaneous injection of l0  T 10ME cells. These cell lines are classified as C type. 
L53  is  an  uncloned  cell  line  established from  a  tumor  in  an  ATxFL  mouse  after  the 
subcutaneous injection of 107 10CR cells. This cell line is classified as C  type. 
L81 and L88 are uncloned cell populations established from tumors in normal mice after the 
subcutaneous injection of L53 and L51, respectively, and are classified as C  type. 
Chromium-release Assay for NK-mediated Lysis.  Spleens were  dispersed into single cells and 
suspended in RPMI-1640 media plus 10% FBS supplemented as previously described (6). 51Cr- 
labeled targets were prepared as previously described (7).  When unlabeled targets were used 
(i.e., competitors), they were mixed with labeled targets before their addition to assay vessels 
containing spleen cells. Assays done in microtiter plates contained 104 5aCr-labeled targets per 
well in 100-/~1 media; whereas assays done in 35-ram dishes utilized 5 ×  104 51Cr-labeled targets 
per dish. The assay vessels were gently rocked for approximately 15 h at 37°C, then centrifuged 
at  160 g  for 5 min, and half of the supernate was collected to determine the amount of 5LCr 
released. 
The percent specific 51Cr released was calculated by the following formula: % specific 51Cr 
release  =  (sample counts  per minute  -  spontaneous counts  per minute)/(total  counts  per 
minute -  spontaneous counts per minute). All data points represent the arithmetic mean of 
51  triplicate samples. In all assays the spontaneous release of  Cr ranged from  16 to 32%. When 
protein synthesis inhibitors were added to the reaction, the spontaneous release was determined 
in the presence of these inhibitors and was slightly higher than in their absence (see Fig. 12). 
Relative sensitivity to NK lysis of different targets can be assessed by comparing the number 
of effector cells required to give an equivalent amount of chromium release, or by comparing 
the amount of chromium released at any one effector concentration. 
Results 
Lysis of I-type  Targets  is  Caused by NK Activity.  Because  I-type ceil  lines  grow  as 
tumors  in  ATxFL  mice,  yet  are  rejected  by  normal  mice,  we  initiated  a  series of 
experiments to determine if T  cell-mediated cytotoxicity, which is absent in ATxFL 
mice, was  responsible for the rejection of the I  lines in normal mice. To  do this we 
examined the in vitro lysis of N,  I, and C  cells by spleen cells from  mice primed in 
vivo  and  boosted  in  vitro  with  appropriate  N,  I,  or  C  cells.  In  summary,  these 
experiments showed that there was no inducible cell-mediated lysis of the targets over 
the lyric activity of the nonimmunized,  control spleen cells. The failure to induce a 
cell-mediated response and the high level of killing observed in vitro by spleen cells 
from  naive mice suggested that  NK-like activity was responsible for the cytotoxicity 
in these experiments. We confirmed this by the following four criteria: 
(a) The lysis of the target cells is not dependent on  immunoglobulin  (Ig)-bearing 
cells because the amount of lysis is not diminished by passing spleen cells through an 
anti-Ig column  (8)  or by the direct addition of purified anti-K light-chain antibody, 
which  inhibits  antibody-dependent  cellular  cytotoxicity,  to  the  chromium-release 
assay (9). 
(b) The spleen cell activity is not reduced by removal of adherent cells or elimination 
of T  cells with anti-Thy  1.2 plus complement or elimination of B  cells by treatment 
with anti-Ig plus complement  (10). 
(c)  The lytic activity of spleen cells is reduced if mice are pretreated with  hydro- 
cortisone, which is known to reduce NK activity (11). 
(d) The lytic activity of spleen cells is not H-2 restricted, which rules out cytotoxic 
T  cells as the  effectors.  It  was  also observed  that  the activity of spleen  cells is  not 92  TUMORIGENICITY AND  NATURAL  KILLER  I,YSIS 
increased  after  tumor inoculation.  We found no evidence for lytic activity that  was 
inducible,  NK or other. 
N  Lines,  Unlike  I  Lines,  are  Resistant  to NK  Lysis.  The  next  series  of experiments 
were designed to see if there was a correlation between  the level of sensitivity to NK 
lysis and tumorigenicity by comparing the NK sensitivity of the N-type parental cell 
line,  B/C-N, and two I-type cell lines derived  from it  (Figs.  1 and 2).  If NK activity 
were responsible for the rejection of I cell lines, then the I-type lines would be sensitive 
to NK lysis. By this same reasoning, the C  type-transformed cells would be resistant 
to NK lysis because these cell lines grow as tumors in mice with normal NK activity. 
Because the nontransformed N-type cell lines do not form tumors in any test mice, we 
would also expect  these cells to be resistant  to NK lysis, along with all other normal 
cells.  In fact, we found the N-type cell line  (B/C-N)  to be relatively  resistant  to NK 
lysis,  whereas  both  I-type  lines  (10ME  and  10CR)  were  found  to  be  extremely 
sensitive. By a direct comparison of the percent specific 51Cr release (at a given spleen 
cell:target  ratio), the I-type lines are approximately  fourfold more sensitive than the 
N-type line. By comparing the spleen cell:target ratio (at a given percent specific 5ZCr 
release),  I-type cells are ~ lfi-fold more sensitive than the N-type cell line. 
A TxFL,  Unlike Normal Mice, are Deficient in NK Activity.  Because I-type cell lines are 
not rejected by ATxFL mice, we tested the in vitro NK lytic activity of ATxFL mouse 
spleens.  As shown in Fig.  3, ATxFL mouse spleen  cells tested on the most sensitive  I 
line  (10ME)  are  very  low  in  NK  activity  5  wk  after  irradiation  and  fetal  liver 
restoration. It has been shown that NK activity is radiosensitive, but gradually returns 
(12)  to near normal  levels after 8  wk.  Similar  results  were observed  for the ATxFL 
mice. The results of these experiments are consistent  with the hypothesis that  I-type 
cell  lines form tumors in ATxFL mice because these animals  have low levels of NK 
activity,  but  do  not  form  tumors  in  normal  mice  because  of normal  levels  of NK 
activity. 
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FIG.  3.  Comparison of the NK activity of spleen cells  from normal mice (O)  and ATxFL mice 5 
wk after irradiation and restoration (O). The target is 10ME. J.  L.  COLLINS,  P.  Q.  PATEK,  AND  M.  COLIN 
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lq¢;.  4.  Competition for the NK lysis of t0CR by 10CR (A) and 10ME (B). The ratio of unlabeled 
targets to labeled targets was 0:1  (A),  1:1  (C)), and 3:1  (0). 
C-type Mutants Derived from  I-type  Cells By Sequential Passage in A TxFL  Then  Normal 
Mice  are Resistant  to NK Lysis.  The cell  lines,  L51  and  L53,  were  established  from 
tumors  that  arose  in ATxFL mice after  the  injection  of the  I-type cell  lines,  10ME 
and  10CR, respectively. These tumor cell lines were found to be capable of forming 
tumors  in both ATxFL and normal  mice in spite of the fact  that  their parental  cell 
lines,  10ME and  10CR, will only form tumors in ATxFL mice. 
The comparison of the tumorigenic potential of L51 and L53 (C type) with that of 
10ME  and  10CR  (I  type)  indicates  that  selection  for increased  tumorigenicity  has 
occurred in the ATxFL mice.  If the selective pressure in ATxFL mice is NK activity 
then  it  must operate  late  in  tumor growth because  these animals  are devoid of NK 
activity at the time when cells are injected, and it must be weak because the uncloned 
tumor cell  lines  (L51  and  L53)  are  NK sensitive  like their parental  I-type cell  lines 
(see Figs.  1C and  2C).  If these populations  (L51  and  L53)  are mixtures of sensitive 
and resistant cells, up to 20% of the cells could be resistant  and go undetected in our 
in vitro NK assay. 
The cell lines,  L88 and L81, were established  without cloning from the passage of 
L51 and L53 in normal mice. The lines, L88 and L81, are NK resistant  (see Figs.  1 D 
and 2 D). From these results it is clear that the ability of a transformed cell to grow as 
a  tumor in normal mice is correlated with resistance to NK-mediated lysis. 
There remain the questions as to why I-type lines are so highly sensitive to NK lysis 
and how N- and C-type cells resist  lysis. To answer these questions we were led to a 94  TUMORIGENICITY  AND  NATURAL  KILLER  LYSIS 
series of experiments aimed at analyzing the NK recognition determinants on these 
sensitive and resistant fibroblast lines. 
NK-resistant  Cells Compete  for NK Lysis of Sensitive Cells.  Fig. 4 shows the NK lysis of 
a  5tCr-labeled  I-type cell  line,  10CR,  and  the  competition  for  the  killing  by  the 
autologous I-type line as well as another independently derived I-type cell line, 10ME. 
A  comparison of these  two curves shows  that  both cell  lines compete equally  well. 
Thus, any determinants recognized by NK cells on  10CR  targets are also expressed 
on  10ME cells.  However, there may be determinants present on  10ME that are not 
expressed on  10CR. In the converse experiment using ~XCr-labeled  10ME target cells 
with unlabeled  10CR and  10ME cells as the competitors (Fig. 5) a similar result was 
obtained,  i.e.,  both  cell  lines  compete  equally  well.  These  reciprocal  experiments 
indicate  that  two  independently  derived  chemically  transformed  clones  that  are 
sensitive to NK lysis, are recognized identically by NK effector cells. Further experi- 
ments using the C-type cell line  L88 to compete for the NK lysis of 10ME showed 
7C 
6( 
50 
40 
30 
20 
10 
A 
7o  ~a  B 
~o 
m  ~,  C 
lO 
o  ,  ,  J  ,  ,  ,  , 
SPLEEN  CELL : LABELED TARGET RATIO 
I"]t~.  5.  Competition  for the NK  lysis of 10ME by  10ME (A),  10CR  (B), and B/C-N  (C). The  ratio 
of unlabeled  targets to labeled targets was 0:1  (A),  1 : 1 (O), and  3:1  (D). j. L. COLLINS, P.  Q.  PATEK, AND M.  COHN  95 
that this Co-type cell line, which is resistant to NK lysis, is also a good competitor (see 
Fig.  6),  and,  therefore, must  also  express  the  same  NK  recognition  determinants 
expressed on 10ME and 10COR. Fig. 5 (2 shows the competition for lysis of chromium- 
labeled 10ME by the N-type fibroblast, B/CO-N. This cell line competes as well as any 
other competitor tested, a  result that  is of key importance because B/CO-N is not  a 
transformed cell and is not a NK-sensitive target. 
In order to determine if cells outside of these lineages also express NK recognition 
determinants, competition experiments were performed using fresh normal tissue as 
well as independently derived cell lines characterized as neuronal and  fibroblastic. 
All cells tested, except adult thymocytes (Fig. 7), WEHI 7, a T  cell lymphoma, and 
the N18 derivative of COl300, a neuronal cell line (Table I) compete in NK lytic assays 
on NK-sensitive fibroblast targets. Because primary fetal fibroblasts, adult fibroblasts 
(Fig. 8), or fibroblastic cell lines BNL 2/5, L47, as well as neuronal and lymphoid cell 
lines (Table I and Fig. 9) act as competitors, the determinants recognized by NK cells 
are not unique to fibroblast targets. 
It is conceivable that some of the competition might be a result of steric hindrance 
of NK effectors in the assay vessel when the number of target cells is increased by the 
addition  of competitor cells.  The  lack of competition by thymocytes (Fig.  7)  and 
CO 1300-N 18 (Table I) indicates that this is not the situation. The failure of thymoeytes 
to  compete  is  not  related  to  their  lack  of adherence  to  plastic  because  another 
nonadherent lymphoid cell line, YAC- 1 (an NK-sensitive target), is a good competitor 
(see Fig.  9).  In addition, because N18 is an adherent cell line, competition is not a 
result of attachment of competitors to the assay vessels.  The lack of competition by 
normal  thymocytes  cannot  simply  be  caused  by  the  difference  in  size  between 
fibroblasts  and  thymocytes because  the  level of competition  by thymocytes at  20 
unlabeled  competitors  to  1  labeled  target  is,  at  best,  equivalent  to  the  level  of 
competition of only  1 unlabeled fibroblast to  1 labeled target. We have performed 
these assays in both microtiter plates and 35-mm dishes with comparable results. In 
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Fro.  6.  Competition for the NK lysis of 10ME by L88.  The ratio of unlabeled targets to labeled 
targets was 0:1  (A), 1:1  (O), and 3:1  ([7). 
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FIG.  7.  Competition of the NK lysis of 10ME  by primary adult and fetal  fibroblast cultures. The 
ratio of labeled  10ME  to NK effectors  (spleen cells) was 1:100. 
TABLE  I 
Competition for the Kilhng of an NK-sensitive Target ( IOME) by Various 
Cell Types 
Unlabeled target (one labeled  10ME/one 
unlabeled target) 
Percent 5tCr released 
at an effector: 
labeled target ratio of 
20:1  10:1 
Experiment 1 
None  89  78 
10ME  62  38 
BNL 2/5*  59  53 
BNL SVA.8*  50  45 
Et R7§  32  22 
C1300 NI8]I  97  83 
Experiment 2 
None  77  60 
10ME  .  53  44 
WEHI 7¶  73  63 
WEHI 7 (unlabeled target: 10ME:20:1)  71  63 
L47"*  43  34 
* Cloned, nontumorigenic BALB/c fibroblastic cell  line derived from mouse 
liver. 
:~ Cloned  cell  line  derived  from BNL  2/5  transformed in  vitro with  SV40 
virus. 
§ Cloned neuronal cell  ~ine from a C57BL/6 mouse (15). 
I] Cloned neuroblastoma cell line from a A/J mouse (16). 
¶ Cloned T  cell  lymphoma from a BALI~/c mouse. 
** Cell  line derived from a tumor in BALB/b mouse after the injection of an 
in vitro chemically transformed BALB/b fibroblast cell line. f,-  ~o 
o  _[ 
Q. 
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Flo.  8.  Competition  for the NK lysis of 10ME by normal thymocytes (A)  and  10ME  (B). The 
ratio of unlabeled targets to labeled targets was 0:1  (A),  1:1  (O), 3:1  (F1), 6:1  (0), 20:1  (m). 
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FIG.  9.  Competition for the NK lysis of 10ME by 10ME and YAC-1. The ratio of unlabeled 10ME 
to labeled  10ME was 0:1  (O) and 3:1  (I-1). The ratio of unlabeled YAC- 1 to labeled  10ME was 1  : 1 
(O), 3:1 (A), 6:1  (I), and  18:1  (A). 98  TUMORIGENICITY AND  NATURAL  KILLER  LYSIS 
microtiter plates there were 500 targets/mm  2 whereas in small dishes there were only 
50 targets/ram  ~. Thus, there appears to be little effect caused by the density of the 
targets or spleen cells within the assay vessels, and, as an approximation, it is the ratio 
of  targets  (labeled  and  unlabeled)  to  spleen  cells  that  determines  the  extent  of 
chromium release. Furthermore, the fact that B/C-N is lysed in the presence of protein 
synthesis inhibitors (see below) indicates that competition by these cells is at the level 
of recognition. 
NK Lysis of Fibroblast Targets Shows a Lag Period.  The competition data imply that 
both sensitive and resistant cells possess the cell surface determinants recognized by 
NK effectors. Therefore, sensitivity or resistance must reside in later steps involving 
either  induction  and/or  activation  of the  lytic  mechanism  or  repair  of the  lytic 
damage (counterlytic activity). 
The lysis of fibroblastic targets shows a  4- to 6-h lag after the mixing of the NK 
effector ceils  (spleen cells)  with the 51Cr-labeled target cells  (Fig.  10). After this lag 
period, the release of SlCr proceeds at a relatively constant rate over the next 8-10 h. 
Because fibroblasts,  but  not  lymphoid targets, show  this  lag period,  we initiated  a 
series of experiments  to  determine  if the  lag represents  the  time required  for NK 
effectors to be activated by fibroblasts target cells. 
The Lag is Not Caused by Activation of NK Effector Cells by Sensitive Targets.  If lysis of 
target cells were dependent  upon activation of NK effector cells, then the lag could 
represent  the  time required  for the  activation.  To test  this  hypothesis,  spleen  cells 
were added to microtiter plates along with 104 unlabeled  10ME, B/C-N, or no target 
cells. 4 h later (t =  4),  104 chromium-labeled 10ME cells were added to all the plates. 
1  h  later  (t  =  5)  and  every  2  h  thereafter  (up  to  t  =  19)  supernates  from  each 
pretreatment group were harvested and the percent specific 51Cr release determined. 
The results of this experiment are shown in Fig.  11. The failure of unlabeled B/C- 
N  or  10ME  added at t  =  0  to alter the lag time of ~lCr release from labeled  10ME 
added at t =  4 indicates that in vitro activation of NK cells is not responsible for the 
lag period. 
Resistance to Lysis is Dependent on Protein Synthesis,  Whereas the Lag is Not.  In order to 
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ofeffectors with  10ME, B/C-N, or nothing. 
test whether the lag was caused by a requirement for de novo  protein synthesis of lytic 
enzymes  by  either  the  target  or  effector cell,  we  performed  the  NK  assay  in  the 
presence  of the  protein  synthesis  inhibitor,  cycloheximide.  If protein  synthesis  is 
required for lysis, then there should be a decrease in the killing of sensitive or resistant 
target cells in the presence of cycloheximide. Although our experiments show that the 
lag period is not due to the requirement for de novo protein synthesis, these experiments 
do show that resistance to NK lysis is dependent on protein synthesis. 
In these experiments two sets of NK assay plates were prepared; one with  10ME as 
the target cell and  the other with  B/C-N as the target cell.  At the initiation  of the 
assay,  and  at  2-h  intervals  thereafter,  cycloheximide was  added  to  one plate  from 
each set  (5  mM);  regardless of when  cycloheximide was added,  all  the assays were 
terminated at  14 h  and the percent specific ~lCr release was determined. The results 
of these  experiments  are  shown  in  Fig.  12.  When  the  NK assay  was  run  with  no 
cycloheximide present  (cycloheximide added at t  --  14),  10ME was lysed (Fig.  12 B), 
whereas B/C-N was NK resistant  (Fig.  12 A). When the assay was allowed to proceed 
for 8-12  h  before the addition  of cycloheximide  (then  4-6 h  in  the presence of the 
inhibitor),  there  was  little  effect  on  the  results.  Surprisingly,  when  the  assay  was 
allowed  to  proceed  for  0-6  h  before  the  addition  of cycloheximide  (8-14  h  with 
cycloheximide), an  increase  in  target  lysis was observed. This is  most striking with 
B/C-N when the assay proceeds for 2 h without cycloheximide and then the remaining 
12 h of the assay period with cycloheximide present (see Fig.  12 A). Here, the control 
level of NK-mediated killing  (i.e., cycloheximide added  at  t  =  14)  was  11%  (spleen 
cell:target ratio of 40:1), whereas the experimental level ofNK lysis at the same spleen 
cell:target  ratio,  with cycloheximide added  at  t  =  2,  was 59%.  Similar results  have 
been observed with every NK-resistant fibroblast tested. 
Cycloheximide blocks protein synthesis preventing both chain initiation and elon- 
gation by an interaction with the 60S ribosomal subunit  (13). Two other inhibitors of 
protein synthesis had effects similar to cycloheximide when added  to the NK assay. 
One  of these,  streptoimidone,  functions  as  does  cycloheximide,  whereas  the  other, 
emetine, functions at the level of the 80S ribosomal unit and not the 60S subunit  (13), 70 
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further supporting our interpretation that the effect of cycloheximide in these exper- 
iments is actually at the level of protein synthesis. 
These results lead to three important conclusions. First, the lag period is not caused 
by induction  of lytic enzymes because the addition of protein synthesis inhibitors  at 
the  beginning  of the  assay  does  not  reduce  lysis.  Second,  B/C-N  must  bear  NK 
recognition determinants because it is lysed by NK effectors when protein synthesis 
inhibitors  are added  at the appropriate times during the assay. This result strongly 
supports our interpretation  that  the competition experiments reflect the presence of 
NK target determinants on both resistant  B/C-N and sensitive I-type cells  (see  Fig. 
5). Third, B/C-N is NK resistant because of a counterlytic mechanism, the expression 
of which depends upon protein synthesis. The NK-sensitive targets (10ME and 10CR) 
must have a lower level of counterlytic activity than the NK-resistant target, B/C-N. 
These conclusions will be developed in the discussion. 
Discussion 
We have analyzed the NK sensitivity of cells at various stages on the pathway to 
cancer. The nontransformed parental N-type cell line, B/C-N, is anchorage dependent 
and nontumorigenic. I-type cell lines are anchorage independent  and grow as tumors 
only in surveillance depressed mice  (ATxFL). C-type cell lines are anchorage inde- 
pendent  and  grow as  tumors in  both ATxFL and  normal  mice. C-type cells  must, 
therefore, escape a surveillance mechanism, which prevents I-type cells from growing 
as tumors in normal mice. 
The observations that I-type lines are sensitive to NK-mediated lysis, whereas the 
nontransformed  N-type and  those transformed C-type lines derived as tumors from 
normal  mice are resistant  to NK-mediated  lysis, are consistent  with  the  hypothesis 
that escape from lysis by NK is obligatory for tumor formation in normal mice. The 
finding  that  those C-type cell lines derived  from tumors formed by the injection of 
I-type lines into ATxFL mice are NK sensitive (e.g., L51, L53) is also consistent with 
this hypothesis because the tumors that develop in the normal mice as a result of the 
injection of either L51  or L53 are NK resistant  (e.g., L81, L88). 
This association between tumorigenicity and NK sensitivity, as predicted by a NK 
surveillance  hypothesis,  is  made  ambiguous  by  the  lack  of a  correlation  between 
binding  specificity  and  either  NK  sensitivity  or  tumorigenicity.  In  addition  to 
competition for NK lysis of one transformed cell line by other transformed cells, the 
nontransformed  parental  cell  line  B/C-N,  as well as primary fibroblasts, neuronal, 
and  lymphoid  cell  lines  also  compete,  which  indicates  that  the  NK  recognition 
determinant  present  on  NK-sensitive cells is also present  on a  variety of cell  types, 
both sensitive and resistant. 
The fact that cycloheximide renders the normally resistant B/C-N sensitive to NK 
lysis confirms our interpretation of the competition studies showing that NK effectors 
recognize determinants present on both sensitive and resistant target cells. The effect 
FIG.  12.  Effects of the addition of cycloheximide on the chromium release assay of NK-mediated 
lysis  of a  resistant,  B/C-N  (A)  and  a  sensitive,  10ME  (B),  target.  The  spontaneous  release  of 
chromium in  the  presence of cycloheximide (t  equals  the  time of addition  of the  cycloheximide) 
from B/C-N  (A) was 26% at t  =  14,  27% at t  =  12, 26% at t  =  10, 26'7,  at  t  ~  8, 25% at t  =  6, 24f7,. 
at  t  =  4,  22% at  t  ~  2, and  22'1,  at  t  =  0. The spontaneous from  10ME  (B)  (t  equals the time of 
addition of cycloheximide) was  16%  at  t  =  14,  20% at  t  =  12,  19% at  t  =  10,  19'/,, at  t  =  8, 27% at 
t  ~6,24%at  t  =4,23%at  t  =2,  and32%at  t  =0. 102  TUMORIGENICITY AND NATURAL KILLER LYSIS 
of cycloheximide further demonstrates that these cells receive lytic signals from NK 
effectors but normally escape lysis by a counterlytic mechanism that requires protein 
synthesis (discussed below). 
The  fact  that  the  NK-resistant  wild-type  B/C-N  expresses  an  NK  recognition 
determinant,  which  is  indistinguished  from  that  expressed  by  the  NK-sensitive 
variants  10ME  and  10CR,  implies  that  the  transformation  that  results  in  the  I 
phenotype does not involve the appearance of new determinants recognized by NK 
effectors. The transformation does, however, result  in an increased sensitivity to the 
lytic  mechanism  initiated  by  NK  cells.  This  is  clearly  different  from  the  general 
findings-with  lymphoid  targets  where  NK  lysis  is  correlated  with  the  presence  of 
surface determinants on only NK-sensitive target cells (4,  14). 
Because the I-type clone  10ME was derived from B/C°N in what appears to be a 
one-step mutation and selection for anchorage-independent growth (not NK sensitiv- 
ity), we assume that anchorage-independent  growth and sensitivity to NK-mediated 
lysis are related by a  common gene control.  Because there are also many examples 
where  the  same  mutagenic  and  selection  procedure  yields  anchorage  independent 
(selected marker), NK-resistant (unselected marker) lines (C type) (1), there are many 
genes not common to the two. This can also be seen by considering the mutation(s) 
I  to C  within a  lineage. These are correlated with a  reduction  in NK sensitivity yet 
the anchorage-independent  phenotype is maintained  (i.e.,  the cells do not  revert to 
the N  phenotype when they become NK resistant). 
Although the precise nature of the selective pressure operating on the I type cells in 
ATxFL mice is not  known,  the  tumor cell  lines  isolated  from them  (L51  and  L53) 
show an increased tumorigenic potential when compared with their parental cell lines 
(10ME and 10CR). This increase in tumorigenicity could be the result of selection for 
either (a) NK resistance or (b) selection for increased tumorigenicity for some reason 
other than resistance to NK-mediated lysis. 
If the selection pressure in ATxFL mice is low-level NK activity, then there is only 
one mutation  (NK sensitive to NK resistant)  required  for an I-type cell to grow as a 
tumor in normal mice. However, we must assume that the direct selection for C-type 
variants from I-type lines does not occur in normal mice because their high level of 
NK activity results in the rejection of the I line before NK-resistant mutants can arise. 
In the ATxFL mouse, the NK activity is low enough to permit sufficient I-line growth 
for  NK-resistant  variants  to  arise;  yet  it  is  high  enough  to  provide  a  selective 
enrichment for the NK-resistant variants. 
If the selection pressure in ATxFL mice is for increased tumorigenic potential not 
related to NK activity, then a second mutation to NK resistance must be selected for 
in normal mice. The probability of obtaining C-type variants in I-cell populations by 
sequential  selection,  first  in  ATxFL  then  in  normal  mice,  would  be  high.  The 
probability of obtaining C-type variants by simultaneously selecting for both muta- 
tions in normal mice would be low. This would explain why C-type variants can only 
be selected sequentially. Our ongoing analysis of the tumorigenicity and NK sensitivity 
of cloned  derivatives of the ATxFL passaged  lines,  L-51  and  L-53, will  resolve the 
number and nature of the mutations required for an I cell to express the C phenotype. 
Whatever the selective pressure is in ATxFL mice, the growth of the ATxFL-passaged 
cell  lines,  L51  and  L53,  as  tumors  in  normal  mice results  in  the  selection  of NK- 
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In spite of the good correlation between the tumorigenic potential of cells within a 
fibroblast lineage and NK sensitivity assayed in vitro, the observation that  normal 
cells or C-type cells that have escaped tumor surveillance carry the NK recognition 
determinant and inhibit the killing of sensitive cells casts doubt on the role of NK as 
an effective in vivo surveillance mechanism. Because B/C-N and YAC-1 express the 
same recognition determinant,  the in vivo efficiency of surveillance of transformed 
lymphoid cells by NK effectors must  also  be  far from optimal.  Without  a  special 
mechanism  (e.g.,  the  localization of NK  effector cells at  the  tumor site or a  high 
turnover rate for NK-target complexes), the competition by normal cells would be 
overwhelming because they are in  vast  excess over any de  novo arising transformed 
cells.  Even if a special mechanism exists, the competition by normal cells would still 
reduce the efficiency of tumor surveillance. The resolution of this apparent paradox 
is crucial to understanding the relationship between the NK system and cancer. 
Two observations bear directly on the mechanism of NK lysis about which we will 
make only general comments. First, the rate of NK lysis depends upon the time when 
protein synthesis is  inhibited  during the NK assay.  Second, NK-sensitive mutants, 
e.g., 10ME, can be derived from the NK-resistant B/C-N, and these cells show similar 
time-dependent patterns of lysis when protein synthesis is blocked. 
The first point demonstrates that the observed rate of lysis is determined by two 
opposing  processes,  a  lytic  process  and  a  counterlytic process.  The  fact  that  the 
observed rate of lysis increasses if protein synthesis is blocked 2 h after initiation of the 
assay indicates that there is induction of a  lytic mechanism within this time period. 
The activity of the lytic mechanism does not require protein synthesis because lysis 
proceeds when inhibitors of protein synthesis are added at the onset of the assay. The 
decline in total specific lysis as protein synthesiss is inhibited at later times (t >  2 h) 
indicates  that  there  is  a  constitutive  counterlytic process  the  activity  of which  is 
dependent  on  protein  synthesis.  As  a  consequence, the  addition  of cycloheximide 
permits an assay of the total lytic activity because it effectively blocks counterlytic 
activity as well as further induction of the lytic mechanism without  impairing the 
lytic activity. The reason  for the  decline in  total specific lysis as cycloheximide is 
added at t >  2 h is simply that the time period decreases over which the total revealed 
lytic activity operates. As a first approximation, the induced lytic potential reaches a 
maximum in t <  2 h and stays at that level for the duration of the experiment. 
The second point shows that the NK-sensitive mutant, 10ME, differs from the NK- 
resistant  parent,  B/C-N,  in  its constitutive level of counterlytic activity. The NK- 
sensitive mutant cannot differ from its NK-resistant parent either in the ability of NK 
effectors to recognize the two targets or in the capacity of the two targets to receive 
lytic signals  and  be  induced to  make  the  lytic mechanism;  both  targets  are  lysed 
similarly  if protein  synthesis  is  blocked at  2  h.  This shows  that  in  the  absence of 
counterlysis, the induced lytic mechanism is roughly the same in both targets. In the 
presence of counterlysis, the B/C-N target is resistant  (counterlysis is high), whereas 
the  10ME target is sensitive (counterlysis is low) because the mutation NK resistant 
to NK sensitive affects the constitutive level of counterlytic activity in the target. 
Whereas the mutation NK resistant  to NK sensitive shows  that  counterlysis is a 
property of the  target,  the  question can  be posed as  to whether the  induced lytic 
activity is synthesized by the effector or the target.  Our unpublished data indicate 
that the induced lytic activity is synthesized by the target as a consequence of the NK 104  TUMORIGENICITY AND NATURAL KILLER LYSIS 
TABLE  II 
Comparison oft& Characteristics of NK Activity Directed at Fibroblasts or Lymphoid Target Cells 
Lymphoid cells  Fibroblasts 
NK-sensitive targets 
sensitive to the  lyric mecha- 
nism 
NK-resistant targets  Not recognized by NK effectors 
(5) but presumed sensitive to 
the lyric mechanism 
Kinetics of lysis as measured by chro-  Linear from t = 0 
mium release 
Effect of cycloheximide  on the lysis of  None* 
NK-resistant targets 
Number of NK recognition determi-  Several (5, 14) 
nants  (as determined  by competi- 
tion studies) 
Recognized by NK effectors  and  Recognized by NK effectors  and 
sensitive to the  lytic mecha- 
nism 
Recognized  by  NK  effectors, 
but  not sensitive to the lyric 
mechanism 
4-6 h lag then linear 
Increases lysis 
Only one detected 
* Data not presented. 
effector  delivering  a  lytic  signal  to  the  target.  The  experiments  presented  here, 
however, leave this question open. 
Our results reveal several differences between the NK-lytic mechanism directed at 
fibroblasts  and  the  lytic  mechanism  directed  at  lymphoid  cells.  Some  of  these 
differences are summarized in Table II. In spite of these differences the fact that YAC- 
1 competes  for the  lysis of 10ME,  indicates  the  same  NK effectors must  recognize 
both  10ME  (fibroblast)  and  YAC-1  (lymphoid)  (see  Fig.  9).  Consequently  the 
difference between the NK-mediated lysis of fibroblasts and lymphoid cells is probably 
not  caused  by  different  NK  effector  populations,  one  for  fibroblasts  and  one  for 
lymphoid cells. We are left then with two explanations for the differences summarized 
in  Table  II:  (a)  NK  effector cells  deliver  one  type of lytic signal,  and  fibroblastic 
targets react differently from lymphoid targets  (most likely), or (b)  NK effector cells 
are capable of delivering two types of lytic signals, one directed at fibroblast  targets, 
the other directed at lymphoid targets. 
One of the major differences between  fibroblast  and lymphoid targets is reflected 
in the kinetics of NK lysis. Fibroblast targets show a 4- to 6-h lag before lysis whereas 
lymphoid targets show no such lag (less  than 0.5 h). Pretreatment  of NK effectors by 
incubation  with  NK-sensitive  targets  does  not  shorten  this  lag  when  the  assay  is 
carried  out on NK-sensitive  targets  (Fig.  11).  Therefore,  any putative  activation  of 
effector cells as a consequence of encountering sensitive targets cannot be the limiting 
factor responsible for the lag period. Further, the lag cannot be a result of the time it 
takes to induce a sufficient level of autolytic enzyme in the target because the level is 
maximal in about  2  h  (see Fig.  12).  At the moment  the lag can be accounted for as 
the time required  to activate this  autolytic enzyme in  the target  and/or  release  the 
5~Cr. Lymphoid targets must differ in one or both of these properties. 
Our studies show that if NK activity plays an important role in tumor surveillance, 
there is a  major missing piece as to how it can function efficiently in vivo. 
Summary 
Detailed analysis of the natural killer (NK) activity directed at nontumorigenic cell 
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On the one hand, a correlation has been found between the tumorigenic potential 
of chemically transformed fibroblast cell lines and their sensitivity to NK cells in vitro. 
Nontransformed cells (N-type cell lines) and cells tumorigenic in normal mice (C-type 
cell lines) are resistant to NK-mediated lysis. In contrast, cell lines that are tumorigenic 
in ATxFL mice (these mice are very low in NK activity), but not in normal mice (I- 
type cell lines) are sensitive to NK-mediated lysis. These findings support the concept 
that NK activity is involved in host surveillance against tumors. 
On the other hand,  NK-resistant  fibroblasts,  whether taken directly from animals 
or derived  as  tumorigenic  or nontumorigenic  cell  lines,  compete with  NK-sensitive 
target cells to inhibit their lysis by NK effectors. Not only are both NK-sensitive and 
-resistant  cells  recognized  by NK  effectors  but  both  receive  lytic signals  from  NK 
effector  cells.  Target  cell  resistance  is  a  result  of  a  protein  synthesis-dependent 
mechanism  that  prevents  lysis  such  that  in  the  presence  of inhibitors  of protein 
synthesis all  fibroblasts tested  are NK sensitive.  Those fibroblasts  that  are normally 
sensitive to NK-mediated lysis must be deficient in their ability to produce or respond 
to  this  counterlytic  mechanism.  These  findings  are  in  contrast  with  the  general 
findings when lymphoid cells are studied as NK targets where sensitivity appears  to 
be a  result of recognition by NK effectors. 
Because  our  findings  show  that  transformed  and  normal  cells  express  the  same 
recognition determinants,  in order for NK activity to play an important in vivo role 
in tumor surveillance, a mechanism must operate to permit NK effectors to find their 
targets  in vivo. In the absence of a  special  discrimination  mechanism,  the killing of 
NK-sensitive transformants  that arise autochronously would be less than optimal as 
a  consequence of competition by the normal, NK-resistant, cells. 
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